by Truveta staff | Apr 25, 2024 | Data, News
Today, we are excited to announce the largest and most complete mother-child electronic health record (EHR) dataset for scientifically rigorous research on mothers and their children. Truveta empowers researchers with unparalleled insights into the continuum of care...
by Truveta staff | Apr 17, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout March 2024 (-32.4%) compared to February 2024. For infants and children, we see a slight increase in respiratory virus-associated hospitalizations; however, rates are...
by Truveta staff | Apr 8, 2024 | Research
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2019 to December 2023. During the early months of the COVID-19 pandemic, the rate of syphilis incidence (e.g., new infection) increased significantly, reaching a...
by Truveta staff | Apr 4, 2024 | Data
US spending on medical devices and in-vitro diagnostics totals more than $199 billion a year, with most of the costs associated with clinical development. Label expansion provides a pathway for recouping costs associated with the device development process by...
by Truveta staff | Apr 2, 2024 | Data
A common misconception is that drugs and devices must gain explicit approval from the FDA for each specific use before healthcare providers can employ them. However, a practice known as off-label use challenges this notion, revealing a broader landscape of treatment...
